Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 may worsen hair loss, and Nourkrin® could be a safe treatment option, but more research is needed.

COVID-19 may cause hair loss conditions like alopecia areata and telogen effluvium.

Hydroxychloroquine may help COVID-19 patients with lupus.

COVID-19 can cause skin symptoms that might help spot the virus early, and treatments for it can also affect the skin.

Teledermatology is crucial and effective for remote skin care in India.

COVID-19 may increase hair loss, and Nourkrin® could help treat it.

COVID-19 increased the number of deaths in 2020 compared to 2018 and 2019.

COVID-19 affects multiple body systems and complicates treatment; accurate testing is crucial.

COVID-19 can cause hair loss, loss of taste and smell, skin changes, and eye problems.

Non-Kuwaitis with COVID-19 had higher chances of severe outcomes than Kuwaitis.

Androgenetic alopecia may increase the severity of COVID-19.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

Many COVID-19 survivors experience long-term symptoms but still report satisfactory quality of life and return to work.

Many patients experience long-lasting symptoms like fatigue and pain after COVID-19, regardless of initial disease severity.

Many COVID-19 survivors continue to experience symptoms like fatigue and concentration problems after recovery, possibly needing rehabilitation.

New treatments for COVID-19 show promise, but more effective antiviral drugs are needed.

Many COVID-19 survivors experience long-lasting symptoms, including hair loss and psychological issues.

The COVID-19 pandemic led to an increase in untreated hair diseases and showed the importance of teledermatology.

A COVID-19 patient with severe hair loss did not improve with hair loss medication after stopping and restarting it due to the infection.

Kidney transplant patients who had COVID-19 experienced a significant drop in their quality of life due to long-lasting symptoms.

The COVID-19 pandemic increased symptoms in people with skin picking and hair pulling disorders.

One-third of COVID-19 patients had long-term symptoms like hair loss and fatigue, with women, older individuals, blood group B, smokers, and those with more virus exposure at higher risk.

A COVID-19 patient had unusual nail discoloration and nail separation possibly due to the virus's effects on small blood vessels.

Skin symptoms linked to COVID-19 are hard to confirm, and more testing is needed to identify which are truly caused by the virus.

Older, obese people with many COVID-19 symptoms are more likely to suffer from severe long-term COVID-19 effects.

Long COVID-19 patients with skin pain might have a nerve condition that responds to a medication called gabapentin.

Hydroxychloroquine, nitazoxanide, and ivermectin were similarly effective in treating early COVID-19.

Early treatment with certain drug combinations improved COVID-19 outcomes and prevented severe disease in males, including those at higher risk.

Most severe COVID-19 patients in Mexico experienced long-lasting symptoms that worsened their quality of life.

The COVID-19 pandemic led to fewer skin checks and skin cancer diagnoses in Australia in 2020.